Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
SiteMatcher: A Web Server for Structure-Based Drug Design Using Protein-Ligand Interaction Patterns
Dongliang Ke1,2, Weiyu Zhou1,2, Zhihan Zhang1,2
1Shanghai Engineering Research Center of Molecular Therapeutics & New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.
SiteMatcher is a new web server that helps design drugs by finding protein-ligand interactions. It uses a fragment-grafting engine to create new molecules complementary to protein pockets, aiding medicinal chemists.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- The Protein Data Bank (PDB) has rapidly growing structural data.
- Efficiently mining protein-ligand interaction patterns is crucial for rational drug design.
Purpose of the Study:
- To present SiteMatcher, a web server for structure-based ligand design.
- To facilitate the identification and utilization of protein-ligand interaction motifs.
Main Methods:
- Developed SiteMatcher, integrating a curated repository of protein-ligand interaction motifs.
- Implemented an automated fragment-grafting engine.
- The engine identifies similar motifs to user-defined protein sites and extracts/merges ligand fragments.
Main Results:
- SiteMatcher enables identification of similar local protein sites.
- Ligand fragments are extracted and merged with seed compounds to generate complementary ligands.
- Leverages site similarity for efficient fragment reuse in ligand design.
Conclusions:
- SiteMatcher provides a practical tool for medicinal chemists.
- Facilitates exploration of diverse ligand design strategies.
- Aims to advance rational drug design through efficient utilization of structural data.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Protein-protein Interfaces
Protein-Protein Interfaces
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...